Checkpoint Blockade in Cancer Immunotherapy
Top Cited Papers
- 1 January 2006
- book chapter
- Published by Elsevier
- Vol. 90, 297-339
- https://doi.org/10.1016/s0065-2776(06)90008-x
Abstract
No abstract availableKeywords
This publication has 158 references indexed in Scilit:
- Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic MelanomaJournal of Immunotherapy, 2004
- B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological SynapseImmunity, 2004
- An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T CellsImmunity, 2004
- CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systemsVaccine, 2004
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- Cross-linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic CellsThe Journal of Experimental Medicine, 2002
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002
- Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinomaEuropean Journal Of Cancer, 1994
- T cell co-stimulation and in vivo toleranceCurrent Opinion in Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993